In press: Early Transfusion of High-titer Plasma Represents the Optimal Use Scenario

Early transfusion of high-titer plasma represents the optimal use scenario to reduce the risk of mortality among patients with COVID-19.

Check out this article to know more right here.


© 2021 by Covid Plasma Initiative Foundation

The Yitzchok Lebovits COVID Plasma Initiative is dedicated in memory of R’ Yitzchok a"h Ben R’ Moshe Eliezer y"blt, who recently passed away. R' Yitzchok was a brother of Chaim Lebovits who has been a driving force behind every aspect of this initiative to bring this life-saving therapy to the people who need it.